Etamsylate | Placebo | |
---|---|---|
*One child in the etamsylate group had a grade 2 haemorrhage, and one in the placebo group had a grade 3 haemorrhage. | ||
Age at death | ||
<7 days | 26 | 23 |
7–28 days | 11 | 5 |
>28 days | 9 | 10 |
Total | 46 | 38 |
Males | 37 | 28 |
Females | 9 | 10 |
Cause of death | ||
Lung disease | 2 | 2 |
Septicaemia | 4 | 4 |
Sudden infant death syndrome | 2 | 1 |
Intestinal obstruction and ventriculitis | 0 | 1 |
Renal failure | 0 | 1 |
Shunt blockage | 0 | 1 |
Perforation of bowel | 0 | 1 |
Hypoplastic left heart | 1 | 0 |
Unknown* | 5 | 3 |
Total | 14 | 14 |